In a groundbreaking move, President Trump has signed a memorandum urging pharmaceutical companies to adhere to transparency laws in their advertising, especially on social media. This initiative aims to ensure accurate drug information and tackle misleading ads, marking a significant shift in health policy.
In a surprising policy shift, President Trump has directed a ban on TV drug advertising, a move that could reshape the pharmaceutical landscape and impact major networks. Discover the implications of this controversial decision!
In a landmark decision, the Trump administration vows to overhaul the regulations on prescription drug advertising. This move aims to ensure consumers receive accurate information about the risks and benefits of medications, combatting misleading ads that favor expensive drugs over affordable generics.
